Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Luttmann

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscleT J Torphy, B J Undem, L B Cieslinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pigD C Underwood, R M Muccitelli, M A Luttmann, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 11, 2000
Differences in time-related cardiopulmonary responses to hypoxia in three rat strainsS Bochnowicz, R R Osborn, M A Luttmann, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1995
Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airwaysR G Goldie, P J Henry, P G Knott, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigsD C Underwood, C J Kotzer, S Bochnowicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dogR N Willette, E H Ohlstein, M P Mitchell, et al.
Journal of Patient Experience|February 6, 2023
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory InfectionsRuth Tal-Singer, Bruce E Miller, Jean M Rommes, et al.
Pulmonary Pharmacology & Therapeutics|April 20, 1999
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive ratD C Underwood, S Bochnowicz, R R Osborn, et al.
British Journal of Pharmacology|April 20, 2001
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout miceD W Hay, S A Douglas, Z Ao, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pigD C Underwood, S Bochnowicz, R R Osborn, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscleT J Torphy, B J Undem, L B Cieslinski, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pigD C Underwood, R M Muccitelli, M A Luttmann, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|August 11, 2000
Differences in time-related cardiopulmonary responses to hypoxia in three rat strainsS Bochnowicz, R R Osborn, M A Luttmann, et al.
American Journal of Respiratory and Critical Care Medicine|November 1, 1995
Endothelin-1 receptor density, distribution, and function in human isolated asthmatic airwaysR G Goldie, P J Henry, P G Knott, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigsD C Underwood, C J Kotzer, S Bochnowicz, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dogR N Willette, E H Ohlstein, M P Mitchell, et al.
Journal of Patient Experience|February 6, 2023
The COPD Foundation's COPD360Net Initiative Approach to Patient-Centric Drug Development: A Case Study in Using Patient Surveys to Inform New Treatments for Viral Respiratory InfectionsRuth Tal-Singer, Bruce E Miller, Jean M Rommes, et al.
Pulmonary Pharmacology & Therapeutics|April 20, 1999
Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive ratD C Underwood, S Bochnowicz, R R Osborn, et al.
British Journal of Pharmacology|April 20, 2001
Differential modulation of endothelin ligand-induced contraction in isolated tracheae from endothelin B (ET(B)) receptor knockout miceD W Hay, S A Douglas, Z Ao, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 24, 1998
Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pigD C Underwood, S Bochnowicz, R R Osborn, et al.
Pageof 6